Impact of Leukapheresis and Biological Risk Markers on Early Mortality in Patients with Hyperleukocytic Acute Myeloid Leukemia.

Medicina (Kaunas) · 2025 · PMC12842899 · PMID 41597321

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significancep = 0.08so close (0.05 < p ≤ 0.1)

The non-LA group had a higher comorbidity index (HCT CI ≥ 2 in LA: 21.4%; non-LA: 41.3%), but it did not reach statistical significance ( p = 0.08).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.